Literature DB >> 23867336

Factors associated with the efficacy of mandibular advancing device treatment in adult OSA patients.

Francesca Milano1, Maria Celeste Billi, Francesca Marra, Giovanni Sorrenti, Antonio Gracco, Giulio A Bonetti.   

Abstract

The aim of this study was to evaluate the anthropometric, demographic, occlusal and cephalometric characteristics of a group of adult obstructive sleep apnea (OSA) patients treated with mandibular advancement devices (MADs) and to determine the factors associated with treatment efficacy. Twenty-three consecutive patients with mild to severe OSA (polysomnographically diagnosed [T0]) were recruited for this prospective study; they were treated with a Silensor(®) appliance, and a polysomnographic exam with the MAD in situ was performed 2 to 3 months later (T1) to evaluate MAD's efficacy. Based on apnea-hypopnea index (AHI) differences between the T0 and T1 values, patients were classified into two groups: completely recovered and not completely recovered patients. The differences in anthropometric, demographic, occlusal and cephalometric parameters between the two groups were analyzed, and significant parameters verified. The sample showed these prevalent characteristics: deep bite, crossbite, tooth wear, dental and skeletal Class II, mesofacial mandibular vertical growth pattern, low position of the hyoid bone, longer soft palate length. The transverse diameters of upper maxilla had the greatest impact on T0 AHI. The factors associated with MAD efficacy were: age under 55 years, distance between the hyoid bone and the mandibular plane (H-MP) less than 20 mm, divergence of mandibular vertical growth pattern (SN^MP) less than 29°.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cephalometry; Oral appliance; Predictability; Sleep apnea; Snoring

Mesh:

Year:  2013        PMID: 23867336     DOI: 10.1016/j.ortho.2013.05.006

Source DB:  PubMed          Journal:  Int Orthod        ISSN: 1761-7727


  9 in total

1.  Time for Surgeons to Think Outside the Anatomical Box.

Authors:  Raj C Dedhia
Journal:  J Clin Sleep Med       Date:  2017-09-15       Impact factor: 4.062

Review 2.  An update on mandibular advancement devices for the treatment of obstructive sleep apnoea hypopnoea syndrome.

Authors:  Shadi Basyuni; Michal Barabas; Tim Quinnell
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

3.  The changes in oral volume and hyoid bone position after maxillomandibular advancement and genioglossus advancement for patients with obstructive sleep apnea.

Authors:  Shouhei Ogisawa; Shuichi Nishikubo; Junya Nakajima; Hiroaki Azaki; Kotoe Mayahara; Keiji Shinozuka; Morio Tonogi
Journal:  Sleep Breath       Date:  2022-04-05       Impact factor: 2.816

Review 4.  Cephalometric predictors of treatment outcome with mandibular advancement devices in adult patients with obstructive sleep apnea: a systematic review.

Authors:  Giulio Alessandri-Bonetti; Daniela Rita Ippolito; Maria Lavinia Bartolucci; Vincenzo D'Antò; Serena Incerti-Parenti
Journal:  Korean J Orthod       Date:  2015-11-20       Impact factor: 1.372

5.  Therapeutic outcomes of mandibular advancement devices as an initial treatment modality for obstructive sleep apnea.

Authors:  Pona Park; Hyoung Won Jeon; Doo Hee Han; Tae-Bin Won; Dong-Young Kim; Chae-Seo Rhee; Hyun Jik Kim
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

6.  Sex differences in mandibular repositioning device therapy effectiveness in patients with obstructive sleep apnea syndrome.

Authors:  Marie-Françoise Vecchierini; Valérie Attali; Jean-Marc Collet; Marie-Pia d'Ortho; Frederic Goutorbe; Jean-Baptiste Kerbrat; Damien Leger; Florent Lavergne; Christelle Monaca; Pierre-Jean Monteyrol; Laurent Morin; Eric Mullens; Bernard Pigearias; Francis Martin; Hauria Khemliche; Lionel Lerousseau; Jean-Claude Meurice; Darius Abedipour; Aurélie Allard-Redon; Alexandre Aranda; Valérie Attali; Frédérique Bavozet; Martine Becu; Wally Beruben; Jerome Bessard; Isabelle Bonafe; Mohammed Boukhana; Bruno Chabrol; Gérard Chatte; Chauvel Lebret; Jean-Marc Collet; Olivier Coste; Nathalie Dumont; Sophie Durand-Amat; Marie-Pia D'ortho; Jean Marc Elbaum; Olivier Gallet De Santerre; Frédéric Goutorbes; Thierry Grandjean; Wilma Guyot; Doniphan Hammer; Carmen Havasi; Pascal Huet; Jean Baptiste Kerbrat; Hauria Khemliche; Christian Koltes; Damien Leger; Laurent Lacassagne; Xavier Laur; Lionel Lerousseau; Olivier Liard; Christophe Loisel; Matthieu Longuet; Anne Mallart; Francis Martin; Frédéric Merle Beral; Jean Claude Meurice; Zoubida Mokhtari; Christelle Monaca; Pierre Jean Monteyrol; Jean-François Muir; Eric Mullens; Dominique Muller; Charles Paoli; François Xavier Petit; Bernard Pigearias; Marc Pradines; Arnauld Prigent; Gil Putterman; Marc Rey; Mickael Samama; Renaud Tamisier; Michel Tiberge; Cyrille Tison; Fabienne Tordjman; Bernard Triolet; Christian Vacher; Marie-Françoise Vecchierini; Alain Verain
Journal:  Sleep Breath       Date:  2018-12-22       Impact factor: 2.655

7.  Craniofacial morphology/phenotypes influence on mandibular range of movement in the design of a mandibular advancement device.

Authors:  P Mayoral Sanz; M Garcia Reyes; A Bataller Torras; J A Cabrera Castillo; M O Lagravère Vich
Journal:  BMC Oral Health       Date:  2021-01-07       Impact factor: 2.757

8.  Mandibular advancement device use in obstructive sleep apnea: ORCADES study 5-year follow-up data.

Authors:  Marie-Françoise Vecchierini; Valérie Attali; Jean-Marc Collet; Marie-Pia d'Ortho; Frederic Goutorbe; Jean-Baptiste Kerbrat; Damien Leger; Florent Lavergne; Christelle Monaca; Pierre-Jean Monteyrol; Eric Mullens; Bernard Pigearias; Francis Martin; Hauria Khemliche; Lionel Lerousseau; Jean-Claude Meurice
Journal:  J Clin Sleep Med       Date:  2021-08-01       Impact factor: 4.324

9.  Side effects of intraoral devices for OSAS treatment.

Authors:  Andressa Otranto de Britto Teixeira; Ana Luiza Ladeia Andrade; Rhita Cristina da Cunha Almeida; Marco Antonio de Oliveira Almeida
Journal:  Braz J Otorhinolaryngol       Date:  2017-10-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.